1Lau GK,Piratvisuth T,Luo KX.Peginterferon alfa-2a(40 KDa)(PEGASYS)monotherapy and in combination withlamivudine is more effective than lamivudine monotheraoyin HBeAg-positive chronic hepatitis B:results from a large,multinational study Hepatology 2004:40(Suppll):171A.
3Stftin S,Crumpacker C,Chatis P.A controlled trial comparing foscarnet with bidarabine for acyclovir 9-resistant macocutaneous herpes simplexs in the acquired immunodeficiency syndrome.N Engl J Med,1991,325:551 ～555.
4Chinese Society of infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Associtation.The programme of prevention and cure for viral hepatitis[J].Zhonghua Ganzangbing Zazhi,2000,8:324-329.
5Melegari M,Scaglioni PP,Wands JR.Hepatitis virus mutants associated with 3TC and famiciclovir administration are replication defective[J].Hepatology,1998,27(10):628-633
4Yan YX,Gao YQ,Sun X,et al.Prevalence of hepatitis C virus andhepatitis B virus infections in HIV-positive Chinese patients[J].Epidemiol Infect,2011,139(3):354-360.
5Roussos A,Koilakou S,Kalafatas I,et al.Lamivudine treatment foracute severe hepatitis B:report of a case and review of the literature[J].Acta Gastroenterol Belg,2008,71(1):30-32.
6Shin SR,Koh KC,Gwak GY,et al.A low viral load predicts ahigher initial virologic response to adefovir in patients with Lamivu-dine-resisitant chronic hepatitis B[J].Gut Liver,2010,4(4):530-536.
